Sign Out
Symptoms and Signs: There is limited experience of Ondansetron overdose. In the majority of cases, symptoms were similar to those already reported in patients receiving recommended doses. Manifestations that have been reported include visual disturbances, severe constipation, hypotension and a vasovagal episode with transient second-degree AV block. Ondansetron prolongs the QT interval in a dose-dependent fashion. ECG monitoring is recommended in cases of overdose.
Paediatric population: Paediatric cases consistent with serotonin syndrome have been reported after inadvertent oral overdoses of Ondansetron (exceeded estimated ingestion of 4 mg/kg) in infants and children aged 12 months to 2 years.
Treatment: There is no specific antidote for Ondansetron, therefore in all cases of suspected overdose, symptomatic and supportive therapy should be given as appropriate.
The use of 'Ipecacuanha' to treat overdose with ondansetron is not recommended, as patients are unlikely to respond due to the anti-emetic action of ondansetron itself. Further management should be as clinically indicated or as recommended by the national poisons centre, where available.
